BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37024111)

  • 41. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study.
    Wang Q; Cheng J; Shang J; Wang Y; Wan J; Yan YQ; Liu WB; Zhang HP; Wang JP; Wang XY; Li ZA; Lin J
    BMJ Open; 2021 Oct; 11(10):e043790. PubMed ID: 34598979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?
    Ozdemir A; Kocak SY; Karabela SN; Yılmaz M
    Nefrologia; 2022; 42(5):549-558. PubMed ID: 34539001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutrophil-to-Lymphocyte Ratio and Cut-off Values as Predictor of Severity and Mortality in COVID-19 Patients in Millennium COVID-19 Care Center, Addis Ababa, Ethiopia.
    Tadesse Z; Bekele Bayissa A; Diriba T; Chernet N; Tsegaye S; Tsega M
    Int J Gen Med; 2022; 15():6739-6755. PubMed ID: 36039306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
    Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
    Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of haematological parameters in patients with COVID-19 and influenza virus infection.
    Kazancioglu S; Bastug A; Ozbay BO; Kemirtlek N; Bodur H
    Epidemiol Infect; 2020 Nov; 148():e272. PubMed ID: 33148349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome.
    Bobcakova A; Petriskova J; Vysehradsky R; Kocan I; Kapustova L; Barnova M; Diamant Z; Jesenak M
    Front Cell Infect Microbiol; 2021; 11():646688. PubMed ID: 33937096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia.
    Damar Çakırca T; Torun A; Çakırca G; Portakal RD
    Int J Clin Pract; 2021 Nov; 75(11):e14781. PubMed ID: 34482573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4
    Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S
    Front Pediatr; 2021; 9():643299. PubMed ID: 33937149
    [No Abstract]   [Full Text] [Related]  

  • 52. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.
    Yan X; Li F; Wang X; Yan J; Zhu F; Tang S; Deng Y; Wang H; Chen R; Yu Z; Li Y; Shang J; Zeng L; Zhao J; Guan C; Liu Q; Chen H; Gong W; Huang X; Zhang YJ; Liu J; Dong X; Zheng W; Nie S; Li D
    J Med Virol; 2020 Nov; 92(11):2573-2581. PubMed ID: 32458459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis?
    Yilmaz H; Cakmak M; Inan O; Darcin T; Akcay A
    Ren Fail; 2015 Mar; 37(2):225-9. PubMed ID: 25394529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
    Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
    Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation between early inflammation indicators and the severity of coronavirus disease 2019].
    Li Y; Lin S; Zhou Y; Pan J; Chen Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):145-149. PubMed ID: 33729130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The utility of neutrophil-to-lymphocyte ratio determined at initial diagnosis in predicting disease stage and discriminating between active and stable disease in patients with sarcoidosis: a cross-sectional study.
    Alparslan Bekir S; Sonkaya E; Ozbaki F; Aydogan Eroglu S; Sertcelik L; Duman D; Kavas M; Agca M; Erdem I; Ozmen I; Boga S; Hazar A; Sevim T; Turker H; Tuncay E; Gungor S; Karakurt Z
    Postgrad Med; 2022 Aug; 134(6):603-608. PubMed ID: 35619233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
    Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
    J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the neutrophil-to-lymphocyte ratio as an indicator for early referral of patients with COVID-19 pneumonia to a high-care facility.
    Retief CA; Retief HJ; Van der Merwe S
    S Afr Med J; 2022 Oct; 112(10):795-799. PubMed ID: 36472334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.